06.01.03
Juvenon, Inc., Orinda, CA, has initiated a clinical trial to evaluate the effect of Juvenon Energy Formula™ on cardiovascular disease patients. The trial, funded by a grant from the National Institutes of Health (NIH), is being conducted at the Whitaker Cardiovascular Institute, a unit of the Boston University School of Medicine. It is designed to assess the effects of Juvenon Energy Formula on endothelial function in elderly patients with coronary artery disease. The Juvenon Energy Formula dietary supplement consists of two mitochondrial-activating components and is meant to improve energy levels, reduce signs of aging in revitalized cells and increase burning of fat for energy. This 40-person trial will determine the effect of Juvenon Energy Formula on the endothelial cells that line the blood vessels. The trial is designed as a double-blind, randomized, placebo-controlled, crossover study and will enroll patients from 55 to 95 years of age with proven coronary artery disease.